Tekcapital PLC said Monday its investee, Belluscura PLC and their research partner Separation Design Group, has filed for a patent application for an oxygen enrichment device that treats patients with acute respiratory distress including patients suffering from coronavirus.

“We are pleased to see the additional progress of Belluscura as it continues to strengthen its intellectual property in the oxygen therapy space to help patients afflicted with acute respiratory distress caused by the Coronavirus, said Clifford Gross, Executive Chairman of Tekcapital.

Panitch Schwarze Belisario & Nadel LLP partner Dennis J. Butler supports clients, including Tekcapital with intellectual property and technology law. Butler’s practice includes representing clients before the U.S. Patent and Trademark Office and foreign patent offices.

To learn more, visit London based outlets Morning Star and Vox Markets.